Lanean...
Review of miglustat for clinical management in Gaucher disease type 1
Gaucher disease is a progressive lysosomal storage disorder caused by the deficiency of glucocerebrosidase, and characterized by intralysosomal storage of glucosylceramide that leads to dysfunction in multiple organ systems. Intravenous enzyme replacement with imiglucerase is the accepted standard f...
Gorde:
Egile nagusia: | |
---|---|
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
Dove Medical Press
2008
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2504062/ https://ncbi.nlm.nih.gov/pubmed/18728838 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|